Clinical Trial Results: mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating mFOLFIRINOX followed by hepatic arterial infusion of floxuridine and dexamethasone with systemic mFOLFIRI for unresectable …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma
• Liver Cancer

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Floxuridine (floxuridine)
• mFOLFIRI
• mFOLFIRINOX

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Phase 2 | Status: TERMINATED | Results posted: 2026-06-25